Nicast Ltd. is an Israeli-based technology-driven company developing a range of medical devices. Nicast possesses cutting-edge expertise and knowledge of electrospinning technology, widely recognized as one of the most promising technologies for the creation of new biomaterials and medical devices with previously unattainable properties and benefits. While electrospinning is generating an explosion of academic interest (with over 2,000 scientific papers published in 2008), it has yet to have moved to the market with medical products.
Nicast is the first and only company to use advanced electrospinning technology to create novel medical devices, and is the first company to have successfully brought to the market a medical device made with this technology.
The Company has a CE Mark for its first product, the AVfloTM vascular access graft, and is developing sales in Europe and Asia.
Nicast has a rich product pipeline with applications for vascular devices, hernia meshes, spinal disc repair devices, drug release and wound care devices; many of these applications address markets exceeding $1 billion each.